文献速递颈动脉与弓上血管

经颈动脉血运重建术后结局按术前症状状态分层

Outcomes after transcarotid artery revascularization stratified by preprocedural symptom status.
PubMed 文献 · J Vasc Surg · 2022-07-04

基于血管质量倡议(VQI)2016至2021年18,477例经颈动脉血运重建(TCAR)患者,按术前症状分层分析院内卒中/死亡。近期卒中(OR 2.8)和近期半球性短暂性脑缺血发作(TIA)(OR 2.0)与较高卒中/死亡风险相关,而近期眼性TIA(OR 0.9)与无症状患者相似;既往症状患者风险亦较高(OR 1.6)。作者认为仅以有症状/无症状分类可能过于简化。

要点

  • TCAR患者中近期卒中者院内卒中/死亡风险约为无症状者的2.8倍(OR 2.8)。
  • 近期半球性TIA者风险约为无症状者的2.0倍(OR 2.0),近期眼性TIA者无显著差异(OR 0.9)。
  • 既往症状(>180天)者风险约为无症状者的1.6倍(OR 1.6)。

核心结论

  • TCAR术后,与无症状状态相比,近期卒中和近期半球性TIA与较高的卒中/死亡 rate 相关,而近期眼性TIA与相似的卒中/死亡 rate 相关。
  • 此外,与无症状状态相比,既往有症状状态与较高的卒中/死亡 rate 相关。
  • 总体而言,作者认为将TCAR患者简单分类为有症状与无症状可能过于简化,应使用患者具体的术前神经症状进行风险评估和结局报告。

研究设计与样本

  • 回顾性队列研究,纳入血管质量倡议(VQI)数据库中2016年至2021年接受经颈动脉血运重建(TCAR)的患者。
  • 共纳入18,477例患者,按术前症状分为无症状、近期(<180天)眼性短暂性脑缺血发作(TIA)、近期半球性TIA、近期卒中或既往有症状(>180天)组。
  • 采用趋势检验比较无症状与近期神经损伤严重程度递增组间的结局,并比较无症状与既往有症状组间的结局。
  • 主要结局为院内卒中/死亡 rate,采用多变量logistic回归校正人口学和合并症。

主要发现

  • 18,477例TCAR患者中,62.0%无症状,3.2%有近期眼性TIA,7.6%有近期半球性TIA,18.0%有近期卒中,9.2%为既往有症状。
  • 近期症状患者中,随着神经损伤严重程度增加,卒中/死亡 rate 升高:无症状1.1% vs 近期眼性TIA 0.8% vs 近期半球性TIA 2.1% vs 近期卒中3.1%(P趋势<0.01)。
  • 既往有症状患者卒中/死亡 rate 高于无症状患者,但差异未达统计学显著(1.7% vs 1.1%;P=0.06)。
  • 风险校正后,与无症状患者相比,近期卒中(OR 2.8;95%CI 2.1-3.7;P<0.01)、近期半球性TIA(OR 2.0;95%CI 1.3-3.0;P<0.01)和既往症状(OR 1.6;95%CI 1.1-2.5;P=0.02)与较高的卒中/死亡 odds 相关;近期眼性TIA无差异(OR 0.9;95%CI 0.4-2.2;P=0.78)。

临床怎么用

  • 作者认为,将TCAR患者简单分类为有症状与无症状可能过于简化,应使用患者具体的术前神经症状进行风险评估和结局报告。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Previous studies on carotid endarterectomy and transfemoral carotid artery stenting demonstrated that perioperative outcomes differed according to preoperative neurologic injury severity, but this has not been assessed in transcarotid artery revascularization (TCAR). In this study, we examined contemporary perioperative outcomes in patients who underwent TCAR stratified by specific preprocedural symptom status. METHODS: Patients who underwent TCAR between 2016 and 2021 in the Vascular Quality Initiative were included. We stratified patients into the following groups based on preprocedural symptoms: asymptomatic, recent (symptoms occurring <180 days before TCAR) ocular transient ischemic attack (TIA), recent hemispheric TIA, recent stroke, or formerly symptomatic (symptoms occurring >180 days before TCAR). First, we used trend tests to assess outcomes in asymptomatic patients versus those with an increasing severity of recent neurologic injury (recent ocular TIA vs recent hemispheric TIA vs recent stroke). Then, we compared outcomes between asymptomatic and formerly symptomatic patients. Our primary outcome was in-hospital stroke/death rates. Multivariable logistic regression was used to adjust for demographics and comorbidities across groups. RESULTS: We identified 18,477 patients undergoing TCAR, of whom 62.0% were asymptomatic, 3.2% had a recent ocular TIA, 7.6a % had recent hemispheric TIA, 18.0% had a recent stroke, and 9.2% were formerly symptomatic. In patients with recent symptoms, we observed higher rates of stroke/death with increasing neurologic injury severity: asymptomatic 1.1% versus recent ocular TIA 0.8% versus recent hemispheric TIA 2.1% versus recent stroke 3.1% (Ptrend < .01). In formerly symptomatic patients, the rate of stroke/death was higher compared with asymptomatic patients, but this difference was not statistically significant (1.7% vs 1.1%; P = .06). After risk adjustment, compared with asymptomatic patients, there was a higher odds of stroke/death in patients with a recent stroke (odds ratio [OR], 2.8; 95% confidence interval [CI], 2.1-3.7; P < .01), a recent hemispheric TIA (OR, 2.0; 95% CI, 1.3-3.0; P < .01), and former symptoms (OR, 1.6; 95% CI, 1.1-2.5; P = .02), but there was no difference in stroke/death rates in patients with a recent ocular TIA (OR, 0.9; 95% CI, 0.4-2.2; P = .78). CONCLUSIONS: After TCAR, compared with asymptomatic status, a recent stroke and a recent hemispheric TIA were associated with higher stroke/death rates, whereas a recent ocular TIA was associated with similar stroke/death rates. In addition, a formerly symptomatic status was associated with higher stroke/death rates compared with an asymptomatic status. Overall, our findings suggest that classifying patients undergoing TCAR as symptomatic versus asymptomatic may be an oversimplification and that patients' specific preoperative neurologic symptoms should instead be used in risk assessment and outcome reporting for TCAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Solomon Y, Rastogi V, Marcaccio CL, et al. Outcomes after transcarotid artery revascularization stratified by preprocedural symptom status. J Vasc Surg. 2022. PMID: 35798281. doi:10.1016/j.jvs.2022.05.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。